Heart Attacks are Preventable!

EP58: Consultation About Statin Intolerance

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary: EP58 - Consultation About Statin Intolerance Introduction Dr. Warwick Bishop, a practicing cardiologist and patient education advocate, conducts a recorded consultation with Brad, a long-term patient with coronary artery plaque, and his wife Joan. The episode explores Brad's recent experience with apparent statin intolerance, featuring joint pain, muscle aches, night sweats, and other symptoms that improved after stopping pravastatin and ezetimibe, while discussing the complexity of distinguishing true drug side effects from other causes. Key Takeaways: A landmark study found that 70% of patients who claimed they couldn't tolerate statins were actually able to take them without side effects when tested in a double-blind, randomized crossover trial, suggesting statins are frequently blamed for unrelated symptoms. About 30% of patients do experience genuine statin side effects, making it crucial to systematically test whether symptoms are truly drug-related rather than assuming causation. Brad's case is particularly important because he tolerated pravastatin well for 10 years without problems, suggesting his recent symptoms may have other causes unrelated to the statin itself. Ezetimibe (a cholesterol-lowering agent) rarely causes side effects because it primarily acts in the gut and is not significantly absorbed into the bloodstream, making it an uncommon culprit for systemic symptoms. Pravastatin should be taken in the evening because it has a shorter half-life and requires the liver's peak metabolic activity during sleep to work effectively. Dr. Bishop's treatment approach prioritizes finding a solution that allows Brad to tolerate medication while managing his high-risk coronary plaque at the distal left main artery, which could suddenly close and cause death without treatment. Multiple alternative options exist if pravastatin proves problematic, including switching to rosuvastatin or using newer PCSK9 inhibitors that work through different mechanisms and may be better tolerated. Patients should never stop cardioprotective medications without consulting their doctor, as this leaves serious cardiac risks unmanaged while the cause of symptoms is determined. Dark urine observed during medication use may indicate dehydration rather than drug toxicity, and symptoms should be monitored systematically when reintroducing medications. Read more

EP57: Second Interview With Senior Gastroenterologist Gautam Ramnath

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary Introduction: Dr. Warwick Bishop, a practicing cardiologist and podcast host, welcomes back Dr. Gautham Ramnath, a senior gastroenterologist from Brisbane with over a decade of private practice experience and additional training in geriatrics and pharmacology. This episode focuses on the challenging clinical overlap between chest pain caused by reflux/gastrointestinal issues versus cardiac-related chest pain, and how both specialists approach diagnosis and management. Key Takeaways: Patient history and symptom description are the most critical starting point for differentiating reflux from cardiac chest pain—specifically listening for acid burning sensations, taste of food, or pain triggered by exertion. Both gastroenterologists and cardiologists treat all chest pain as potentially cardiac in origin initially due to serious health consequences, even when gastrointestinal causes seem likely. Chest pain perception is imprecise because nerves are distributed in bands across the chest; both reflux and cardiac conditions can cause similar segmental pain patterns, making differentiation difficult. Alarm features requiring urgent endoscopic evaluation include dysphagia (difficulty swallowing), anemia, iron deficiency, waking up with food in mouth, and changes in swallowing—dysphagia is the gastroenterology equivalent of crushing chest pain on exertion. Topical antacids (like Gaviscon) can be used as a diagnostic trial in younger patients; if symptoms resolve quickly, it suggests local gastrointestinal inflammation rather than cardiac disease. Upper endoscopy is a safe, minimally invasive procedure (major complication rate <1 in 2,000-3,000) that provides direct visual assessment of the esophagus and stomach to identify damage severity, precancerous changes, and determine the exact problem location. Alcohol is a major caustic irritant that severely impedes resolution of esophageal and gastric ulceration and should be identified during patient evaluation. Certain medications can cause reflux-like symptoms: doxycycline (antibiotic) can cause focal ulcers, asthma inhalers can cause candida/thrush infection (commonly misdiagnosed as reflux), and other caustic agents may irritate the esophagus. Functional disorders involving misfiring nerves can present with reflux-like symptoms even when no physical inflammation is present, requiring different treatment approaches. Read more

EP56: Interview With Senior Gastroenterologist Gautam Ramnath

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary: EP56 - Aspirin and Gastrointestinal Health Introduction Dr. Warwick Bishop, a practicing cardiologist and author focused on patient education, interviews Dr. Gautam Ramnath, a senior gastroenterologist from Queensland with over 10 years of experience in gastroenterology practice in Brisbane. The episode explores aspirin from two opposing medical perspectives—its cardiovascular benefits versus its gastrointestinal risks—to help patients understand the complex trade-offs involved in aspirin therapy. Key Takeaways: Aspirin has a "double whammy" effect on gastrointestinal bleeding: it removes the stomach's protective mucus coating while simultaneously impairing the blood's ability to clot, creating a compounded bleeding risk. Aspirin causes stomach ulcers through systemic action after being absorbed into the bloodstream, not through direct contact in the stomach, meaning enteric-coated aspirin offers no meaningful protection. Enteric-coated aspirin preparations provide primarily psychological reassurance rather than clinical benefit, with no scientific evidence showing reduced bleeding complications compared to regular aspirin. The current standard aspirin dose of 100 milligrams in Australia lacks clear evidence of equivalence to the original 300-600 milligram doses used in landmark trials that proved aspirin's cardiovascular benefit. The assumption that lower aspirin doses provide the same cardiac protection as higher doses remains unsubstantiated, potentially undermining current prescribing guidelines. A gastroenterologist with cardiac risk would choose 300 milligrams of aspirin daily, acknowledging the lack of definitive trials proving that lower doses are equally effective. Platelet resistance is a recognized phenomenon where clotting cells may not respond adequately to aspirin, potentially requiring higher doses for efficacy in many patients. Cost-benefit analysis suggests generic soluble aspirin from commercial sources performs similarly to expensive enteric-coated preparations. Read more

EP55: Talking About Supplements

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary: EP55 - Talking About Supplements Dr. Warwick Bishop is a practicing cardiologist and author dedicated to improving patient care through education about heart health. In this episode, he addresses common patient questions about supplements for cholesterol management, specifically discussing bergamot and other natural alternatives to traditional statin therapy. The discussion centers on how to safely and effectively incorporate supplements into a cardiovascular health regimen based on individual risk assessment. Key Takeaways: Bergamot, a citrus-based plant containing flavonoids, has demonstrated cholesterol-lowering effects in research, with studies showing reductions of 0.5-1 millimole per litre and improvements in carotid artery thickness. The effectiveness of any supplement depends on the patient's individual cardiovascular risk level; high-risk patients (those who have had heart attacks) require aggressive LDL lowering and may need statins combined with supplements, while low-risk patients may benefit from supplements alone. When using supplements like bergamot, it is critical to use formulations that actually work—Dr. Bishop recommends using the specific proprietary preparation (BurgerVit) tested in research and monitoring cholesterol levels to verify effectiveness. Red yeast rice, which naturally contains the chemical precursor to statins, can be a supportive option for cholesterol management but may be insufficient as a standalone treatment for high-risk patients. Berberine appears to have lipid-lowering effects that partially replicate PCSK9 inhibitors (newer injectable cholesterol medications) and may have a role in comprehensive cholesterol management. Nicotinic acid (niacin), a B-group vitamin, can modestly lower LDL cholesterol, raise HDL cholesterol, and lower triglycerides, with particular benefit shown in the HATS trial for patients with low HDL cholesterol. Any supplement use should be done in collaboration with a cardiologist or healthcare provider who can monitor its effectiveness, check for side effects, and ensure it doesn't negatively impact organs like the kidneys and liver. Dr. Bishop recommends patients work with both a knowledgeable naturopath and their cardiologist when using supplements, as he acknowledges he cannot stay current with all formulations and proprietary preparations available. Statins remain the gold standard for cholesterol lowering in high-risk patients, but supplements can be valuable additions to a structured, supervised treatment plan when appropriate. The overall approach should balance the patient's actual cardiovascular risk with the intensity of treatment needed, rather than applying one-size-fits-all solutions to cholesterol management. Read more

EP54: Cholesterol Tests: The Good, The Bad, And The Ugly

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary Introduction: Dr. Warwick Bishop is a practicing cardiologist and author dedicated to improving patient care through heart health education. In this episode, he provides a comprehensive breakdown of cholesterol tests, explaining what each component measures and why understanding these numbers matters for assessing cardiovascular risk. Key Takeaways: Fasting for 8 hours before a cholesterol test is optimal; fasting longer than 12-14 hours can skew results as the body makes metabolic adjustments. Total cholesterol measures all cholesterol in the blood and should ideally be around 5-5.5 millimoles per litre. Triglycerides are free fats in the bloodstream and should be below 2 millimoles per litre; elevated levels may indicate recent eating, diabetes risk, or excess weight. HDL cholesterol is "good cholesterol" that removes cholesterol from tissues and returns it to the liver; levels should ideally exceed 1 millimole per litre. LDL cholesterol is "bad cholesterol" because extensive research shows that lowering it in high-risk patients leads to better health outcomes. The cholesterol ratio (HDL to total cholesterol) should be less than 4, as lower ratios indicate a more favorable lipid profile. Primary prevention guidelines recommend LDL cholesterol targets below 2 millimoles per litre, while secondary prevention (after a cardiac event) targets below 1.8 millimoles per litre. Emerging research suggests even lower LDL targets below 1 millimole per litre may benefit high-risk patients with no adverse effects. Dr. Bishop prefers fasting cholesterol tests because they allow simultaneous measurement of glucose and insulin levels to calculate insulin resistance using the HOMA calculation. Cholesterol numbers alone don't tell the complete story; blood pressure, blood glucose, insulin levels, and lifestyle factors are equally important for cardiovascular health assessment. Read more

EP53: What Is Cholesterol?

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary Introduction Dr. Warwick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health, believing that informed patients receive better care. In this episode, he provides a foundational explanation of cholesterol—its chemical nature, biological functions, and how the body transports and manages it. Key Takeaways: Cholesterol is a steroid alcohol, a fatty compound that serves as an essential building block for cell membranes throughout the body. The body uses cholesterol to produce bile acids in the liver, which help break down and transport fats through the digestive system for removal. Cholesterol is a precursor for steroid hormones, including sex hormones like estrogen and testosterone. Because cholesterol is water-insoluble, the body requires special transport molecules called lipoproteins to move it through the bloodstream. The body produces the vast majority of its cholesterol internally through metabolic processes in the liver, with genetics playing a major role in determining production levels. Low-density lipoprotein (LDL) is the primary carrier that transports cholesterol from the liver to body tissues and is the type associated with coronary artery disease risk. High-density lipoprotein (HDL) performs reverse cholesterol transport, picking up excess cholesterol from tissues and returning it to the liver for disposal. Cholesterol metabolism involves three interconnected processes: endogenous production in the liver, exogenous consumption from diet, and reverse cholesterol transport back to the liver. Statin medications work by blocking the HMG-CoA enzyme, which reduces the body's internal cholesterol production. Read more

EP52: Wishes At End Of Life

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. EP52: Wishes At End Of Life - Summary Dr. Warwick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health and improving their care. In this episode, he addresses end-of-life wishes and Medical Orders for Life Sustaining Treatment (MOLST) forms, exploring both their benefits and limitations in documenting patient preferences during critical illness. Drawing on nearly 30 years of experience in end-of-life care decisions, Dr. Bishop advocates for thoughtful, ongoing conversations rather than relying solely on standardized forms. Key Takeaways: MOLST forms provide valuable documentation of patient and family wishes, allowing specific preferences like refusing blood products or resuscitation to be clearly recorded in medical notes. Forms are inherently "brittle" and cannot easily capture the nuances and complexities of individual patient situations or reflect moment-to-moment changes in medical conditions. The presence of a MOLST form noting "no resuscitation" can create a subconscious perception among ward staff that leads to a step-down in overall care quality for patients. Timing matters critically—filling out MOLST forms during a patient's first hours in the hospital creates uncomfortable conversations and puts pressure on junior doctors, patients, and families who are unprepared. End-of-life conversations require deep understanding built over time; Dr. Bishop is only comfortable having these discussions with patients he has known for months or years. Most patients prioritize living with dignity and functionality, wanting to avoid becoming "a vegetable" or entirely dependent on machines or other people. Decision-making about end-of-life care should be flexible and adaptive, made as challenges arise rather than fixed in advance, because medical situations can change unpredictably. Dr. Bishop recommends discussing end-of-life preferences with family broadly rather than waiting for a crisis, allowing people to express their values before facing critical illness. Read more

EP51: Aspirin: Good or Bad?

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary EP51: Aspirin: Good or Bad? Dr. Warwick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health. In this episode, he addresses recent media headlines questioning aspirin's benefits by examining three major clinical trials—ASPRI, ARRIVE, and ASCEND—that collectively studied over 45,000 patients to clarify when aspirin is actually beneficial and when it isn't necessary. Key Takeaways: Recent headlines warning against aspirin are based on large, robust trials (ASPRI, ARRIVE, ASCEND) showing that healthy individuals and average-risk patients don't need aspirin for disease prevention. The ASPRI trial of 20,000 people over age 70 found that regular aspirin didn't improve quality of life, cardiovascular outcomes, or reduce dementia in healthy elderly individuals. The ARRIVE trial showed aspirin reduced heart attack risk in intermediate-risk patients but offered no significant benefit for stroke and came with increased bleeding risk. The ASCEND trial of over 15,000 asymptomatic diabetics over seven years showed aspirin was not compelling for primary prevention in this population. Aspirin remains strongly beneficial in secondary prevention—for patients who have already experienced a heart attack, stroke, stent placement, bypass surgery, or peripheral vascular disease. Dr. Bishop prescribes aspirin in primary prevention only for high-risk patients he has imaged and confirmed have significant plaque buildup in their coronary arteries. The key message is that aspirin decisions should never be based on headlines alone but require individualized conversations between patients and their doctors about specific risk-benefit ratios. Patients currently taking aspirin prescribed by their doctor should not stop without consulting their physician, as the recent trials don't apply to those with existing cardiovascular disease or high-risk imaging findings. Read more

EP50: 50th Podcast

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary: EP50: 50th Podcast Introduction: Dr. Warwick Bishop is a practicing cardiologist and author dedicated to improving patient care through heart health education. In this milestone 50th episode, he celebrates nearly a year of weekly podcasting and reflects on his growing community engagement, including his new role as AMCAL's Heart Health Ambassador and plans to launch an internet-based membership site called the Healthy Heart Network. Key Takeaways: Dr. Bishop has successfully released 50 weekly podcasts over nearly a year, establishing himself as a consistent educator in cardiac health The podcast has reached hundreds of downloads with an engaged community including nearly 1,000 members in the Know Your Real Risk of Heart Attack Facebook group Dr. Bishop has grown his professional network to nearly 4,000 LinkedIn connections and regularly sells e-books internationally, indicating global interest in his content He was appointed as AMCAL's Heart Health Ambassador, expanding his platform and credibility in cardiac health education Dr. Bishop spent time in the United States recording a 13-episode TV series called "The Healthy Heart Network TV Show" to expand his educational reach The upcoming Healthy Heart Network membership site will provide comprehensive, up-to-date information and resources for people seeking quality heart health guidance Dr. Bishop emphasizes that educated patients consistently receive better healthcare outcomes, making patient education his core mission He encourages listener feedback and welcomes questions about topics for future podcast episodes to ensure content relevance Read more

EP49: Takotsubo or Broken Heart Syndrome

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction Dr. Warwick Bishop is a practicing cardiologist and author dedicated to patient education in heart health, hosting this episode to discuss Takotsubo Syndrome, commonly known as Broken Heart Syndrome. The episode explores how severe emotional stress can trigger a heart condition that mimics a heart attack but is caused by nervous system and hormonal responses rather than blocked arteries. This educational discussion aims to help patients understand this rare but important cardiac condition. Key Takeaways: Takotsubo Syndrome (Broken Heart Syndrome) is triggered by significant emotional stress in approximately 70% of cases, such as fights, distressing life events, surgical anxiety, or intense emotional situations like soccer games. The condition predominantly affects middle-aged women, though it can occur in men at much lower frequency. Takotsubo presents identically to a heart attack with chest pain, ECG changes, and elevated troponin levels in blood tests, making it difficult to distinguish without further investigation. The characteristic feature is "apical ballooning," where the heart base functions normally but the apex (tip) balloons outward, resembling an octopus pot—the Japanese origin of its name. Takotsubo is caused by excessive nervous system activity and stress hormones from the adrenal glands affecting heart muscle function, not by blocked coronary arteries. The diagnosis is made by exclusion—patients must show all features of a heart attack while having clear, unblocked coronary arteries. The condition is relatively rare, occurring in approximately 5-10% of people presenting with apparent heart attack symptoms, and is rarely fatal. Most patients recover fully within several months, and recurrent episodes occur in only about 10% of cases. Treatment involves medications for heart failure and beta-blockers to reduce nervous system activity and hormonal impact on the heart. Follow-up care includes coronary angiography or CT imaging to rule out blocked arteries, plus an ultrasound and ECG at three months to confirm full heart recovery. Read more